Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Office-based interventional labs see boost in pay in 2026
CMS has made it a priority to increase payments for procedures performed by office-based labs and ambulatory surgical centers. This was reflected in policy changes made as part of the 2026 Medicare Physicians Fee Schedule.
Boston Scientific to acquire Penumbra for $14.5B
This is a cash and stock transaction that values Penumbra at $374 per share. The move helps Boston Scientific expand its vascular and neurovascular portfolios, gaining new treatments for pulmonary embolism, stroke, deep vein thrombosis and many other critical cardiovascular conditions.
TAVR’s next big challenge: Providing consistent relief for heart patients with aortic regurgitation
TAVR has already transformed care for patients with severe aortic stenosis. Will it make a similar impact on the treatment of aortic regurgitation?
New theranostic could potentially cure difficult-to-treat gastric and pancreatic cancers
Researchers believe new research findings relating to the PET technique signal its potential “to meaningfully change patient care.”
Google rolls out 2 new open access AI models aimed at medical imaging
The tech giant is making each model publicly available so that researchers and developers can have access to the updated technology.

The use of intravascular lithotripsy (IVL) during percutaneous coronary intervention (PCI) is still safe and effective when patients present with calcified nodules (CNs), according to new long-term data published in EuroIntervention.[1] Researchers compared outcomes from patients with and without CNs, highlighting key similarities in stent expansion and luminal gain.

Is IVL safe for patients with diabetes?

New two-year data confirm that the IVL technology developed by Shockwave Medical can be used to treat diabetic patients who require PCI.

Arnold Seto, MD, MPA, FACC, FSCAI, cath lab director, Long Beach VA Medical Center, professor of medicine at Charles Drew University, Society for Cardiovascular Angiography and Interventions (SCAI) treasurer and chair of the SCAI Advocacy Committee, explains the new CPT reimbursement codes being introduced in January 2026 and their impact on practice.

CPT code updates in 2026 will change how interventional cardiologists get paid

A variety of CPT code changes take effect in 2026, and many of them will make a direct impact on interventional cardiology. Arnold Seto, MD, spoke to Cardiovascular Business about these updates for a new video interview.

M-TEER still beneficial for high-risk patients with smaller mitral valve areas

Mitral valve surgery can be especially challenging when patients present with a small mitral valve area. When it comes to M-TEER, however, treatment still appears to be both safe and effective.

Choon-Sik Jhun, MS, PhD, from Penn State

Researchers receive $3.2M in federal funding to test new heart pump for children

The device, currently just a prototype, could be the first of its kind to gain FDA approval.

Diabetes associated with much higher risk of sudden cardiac death

According to a new study of nearly 7,000 patients, type 1 and type 2 diabetes are both linked to significantly shorter life expectancies. The risk of sudden cardiac death appears to be highest for younger patients.

medical students artificial intelligence AI

Match Day results put spotlight on interventional cardiology’s workforce woes

Interventional cardiology's second Match Day was a significant success. Due to a lack of candidates, however, dozens of fellowship positions remain unfilled.

Neuralink users reveal power to move robotic arms, play video games with their minds

The results were shown in multiple posts on X. A clinical trial to prove the safety and efficacy of Elon Musk's brain implant is ongoing, with 12 people currently using the devices.

TAVR still a safe treatment option for immunocompromised patients

While patients with a weakened immune system are still more likely to die after TAVR than other patients, those deaths are largely not related to the procedure or any other cardiovascular issues. This new meta-analysis explored data from a variety of clinical trials.

Clinical

Office-based interventional labs see boost in pay in 2026

Boston Scientific to acquire Penumbra for $14.5B

TAVR’s next big challenge: Providing consistent relief for heart patients with aortic regurgitation

New theranostic could potentially cure difficult-to-treat gastric and pancreatic cancers

Google rolls out 2 new open access AI models aimed at medical imaging